Cargando…
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
SIMPLE SUMMARY: Ovarian cancer is the fifth most common cancer in the developing world, with many front-line treatments combining paclitaxel with platinum-based anticancer agents cisplatin/carboplatin. However, increased incidence of platinum resistance demands the development of new chemotherapeuti...
Autores principales: | Kladnik, Jerneja, Coverdale, James P. C., Kljun, Jakob, Burmeister, Hilke, Lippman, Petra, Ellis, Francesca G., Jones, Alan M., Ott, Ingo, Romero-Canelón, Isolda, Turel, Iztok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160969/ https://www.ncbi.nlm.nih.gov/pubmed/34065335 http://dx.doi.org/10.3390/cancers13102493 |
Ejemplares similares
-
Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
por: Kladnik, Jerneja, et al.
Publicado: (2020) -
Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected β-Diketone, 8-Hydroxyquinoline and Pyrithione Ligands
por: Pivarcsik, Tamás, et al.
Publicado: (2021) -
Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS
por: Marković, Katarina, et al.
Publicado: (2020) -
Pyrithione metal (Cu, Ni, Ru) complexes as photo-catalysts for styrene oxide production
por: Dasireddy, Venkata D. B. C., et al.
Publicado: (2021) -
Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes
por: Trobec, Tomaž, et al.
Publicado: (2021)